A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma

NCT00001300 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

NIH

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: doxorubicin
DRUG: ifosfamide
DRUG: mesna

Sponsor

National Cancer Institute (NCI)